A post-hoc analysis combined kidney measurements from the phase 2 diabetes and obesity trials at 36 and 48 weeks.
What the researchers measured
Urine albumin-to-creatinine ratio and estimated kidney filtration using creatinine, cystatin C, or both were assessed.
How to read this evidence
This analysis uses participants from an existing trial to examine another question. It adds information, but is not a separate trial or independent replication.
Results in context
Most participants had normal baseline urine albumin, so absolute changes were modest. Changes in estimated filtration or urine markers do not establish prevention of kidney failure.
What this does not establish
Most participants had normal baseline albumin excretion. These secondary analyses are not independent kidney-outcome trials.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.
Publication indexing
Journal Article
Source checked
October 4, 2026. Years follow journal issues; online-first dates may differ.